---
schema_version: "secwatch.filing_event.v1"
accession: "0001326110-24-000069"
form_type: "8-K"
ticker: "IBRX"
cik: "0001326110"
company_name: "ImmunityBio, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:47:55.025797+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# ImmunityBio annual meeting: directors re-elected, equity plan shares increased by 19.9M

## Summary
- All nine director nominees re-elected, including Patrick Soon-Shiong, with over 556M votes For each.
- Amendment to increase authorized shares under 2015 Equity Incentive Plan by 19.9M shares approved (547M For).
- Say-on-pay advisory vote approved with 556.7M For votes.
- Ratification of Ernst & Young as auditor for FY2024 ratified (606.9M For).

## SEC filing metadata
- accession: 0001326110-24-000069
- form_type: 8-K
- ticker: IBRX
- cik: 0001326110
- company_name: ImmunityBio, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326110/000132611024000069/0001326110-24-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326110/000132611024000069/ibrx-20240611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001326110-24-000069
- JSON: https://secwatch.observer/filing/0001326110-24-000069.json
- Plain text: https://secwatch.observer/filing/0001326110-24-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.